MindMaze Therapeutics (SIX: MMTX) announced that Dr. John Krakauer has joined as a strategic advisor to support its next stage of growth. No financial figures, guidance, or transaction terms were provided in the available release excerpt.
MindMaze Therapeutics (SIX: MMTX) announced that Dr. John Krakauer has joined as a strategic advisor to support its next stage of growth. No financial figures, guidance, or transaction terms were provided in the available release excerpt.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
